site stats

Cydy sec filings

WebSection 16 Filings Filing Type: View All 10-Q 10-Q/A 10QSB 10QSB/A NT 10-Q Year: View All 2024 2024 2024 2024 2024 2024 2024 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 WebAug 31, 2024 · SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended August 31, 2024 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1933 …

Cytodyn Inc. (CYDY) 10-Q Quarterly Report October 2024

WebJul 2, 2024 · Since 2024, there have been 4 Schedule 13D forms (beneficial ownership report) filed for the company CytoDyn Inc. (stock symbol CYDY) by 3 beneficial owners. A schedule 13D is filed when a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company's equity securities. WebNov 30, 2024 · QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended November 30, 2024 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES ACT OF 1933 For the transition period from to Commission File Number: … implan slp pdf https://ristorantealringraziamento.com

CytoDyn Inc. Quarterly Report (Form10) - CytoDyn (OTC:CYDY)

WebDec 7, 2024 · SEC gov • December 07, 2024 ... Download. Exhibits 8-K EX-10.1. Advertisement. Advertisement. Related Filings from CYDY. 10-Q Quarterly report pursuant to Section 13 or 15(d) Jan 09, 2024. 8-K ... WebJan 9, 2024 · Latest Quarterly or Annual Filing. 10-Q. January 9, 2024. Quarterly report pursuant to Section 13 or 15 (d) WebCytoDyn Inc. focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 … implan ortopedi

Yahoo Finance - Stock Market Live, Quotes, Business & Finance …

Category:All SEC Filings :: CytoDyn Inc. (CYDY)

Tags:Cydy sec filings

Cydy sec filings

CYDY / CytoDyn Inc - SEC Filings, Annual Report, Proxy …

WebSEC gov • April 10, 2024 ... Actions Download. Exhibits EX-31.1 EX-31.2 EX-32 10-Q. Advertisement. Advertisement. Related Filings from CYDY. 8-K Current report filing. Mar 08, 2024. 8-K Current ... WebSEC gov • April 10, 2024 ... Actions Download. Exhibits EX-31.1 EX-31.2 EX-32 10-Q. Advertisement. Advertisement. Related Filings from CYDY. 8-K Current report filing. …

Cydy sec filings

Did you know?

WebMay 31, 2024 · ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. ... Generally, patents issued in the U.S. are effective for either (i) 20 years from the earliest asserted filing date, if the application was filed on or after June 8, 1995, or (ii) the longer of 17 years from the date of issue or 20 … WebSection 16 Filings Filing Type: View All 10-K 10-K/A 10KSB 10KSB/A ARS NT 10-K Year: View All 2024 2024 2024 2024 2024 2024 2024 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

WebApr 10, 2024 · A high-level overview of CytoDyn Inc. (CYDY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. ... SEC Filings. Type: All. WebCYDY CytoDyn Inc. SEC Filings MarketWatch Home Investing Quotes Stocks United States CYDY Finanicals Stock Screener Earnings Calendar Sectors CYDY U.S.: OTC …

WebThe list of stock purchases and sales identified in the SEC filing [1] starts on 1/30/2024 and ends on 6/30/2024. During that period , Thomas Errico, M.D. sold 1,759,422 more shares than he bought, and Paul A. Rosenbaum sold 279,000 more shares than he bought. ... Lastly, I’m fervently hoping that CYDY includes two new replacement independent ...

WebFind the latest CytoDyn Inc. (CYDY) stock quote, history, news and other vital information to help you with your stock trading and investing.

WebJul 27, 2024 · Cytodyn Inc. (CYDY) SEC Filing 10-K Annual report for the fiscal year ending Thursday, May 31, 2024 Home SEC Filings Cytodyn Inc. (CYDY) 10-K Annual Report Fri Jul 27 2024 10-K Annual Report Summary 10-K Annual Report 10-K YoY Changes Cytodyn Inc. CIK: 1175680 Ticker: CYDY GET DIRECTION ON YOUR INVESTMENTS implan stands forWebCurrent report filing. 2. 04/25/22. D/A. Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4 (a) (5) under the Act. 6. 04/22/22. implan sector 15WebApr 11, 2024 · Ticker: CYDY CIK: 1175680 Form Type: 10-Q Quarterly Report Accession Number: 0001558370-22-005291 Submitted to the SEC: Mon Apr 11 2024 5:19:33 PM … implan sscreWeb11 rows · Current report filing. 4. 02/14/23. 4. Statement of changes in beneficial ownership of securities. 1. 02/09/23. CytoDyn is a publicly traded late stage biotechnology company developing … implan sectorsWebCYDY / CytoDyn Inc - SEC Filings, Annual Report, Proxy Statement EXTENDED Overview Owners Insiders Short Interest Filings Financials Dividends Earnings Forecast SEC … lite-on powerWebApr 12, 2024 · CYDY CytoDyn Inc: Wall Street is to the SEC what Big Pharma is to the FDA, but on a tiny scale. Not a conspiracy, bu - #6560037 implantable vagus nerve stimulatorWebApr 10, 2024 · Latest SEC filings for CytoDyn Inc. (CYDY). If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. lite-on power technology dongguan co. ltd